Exil No Worm

Quick links to important sections

Exil No Worm

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Exil No Worm

Property Description
Active Ingredient Fenbendazole
Form Oral (Tablet/Suspension)
Pharmacological Class Benzimidazole Anthelmintic
Primary Use Management of gastrointestinal worms in companion animals
Origin Synthetic

What is Exil No Worm and What Does it Treat?

Exil No Worm is an established brand name for a veterinary medicine containing the active ingredient fenbendazole, which is classified as a broad-spectrum antihelminthic drug. It is specifically designed to eliminate various intestinal parasites, including roundworms and tapeworms (such as Taenia species) in domestic animals. This medication is typically supplied in an oral form, such as chewable tablets or a suspension, which is often favored for its ease of mixing into a pet's food. The use of fenbendazole as a deworming agent is recognized across the veterinary field. The compound's margin of safety, even at doses several times the therapeutic level, is noted in pharmacological profiles.


Active Ingredient Profile and Distinctive Features

The key component in Exil No Worm is Fenbendazole, a synthetic compound belonging to the well-established benzimidazole carbamate class of anthelmintics. This class is globally utilized in animal health for its efficacy against both the adult and larval stages of many parasitic worms. The safety profile of Fenbendazole has been evaluated, establishing it as a standard treatment. Fenbendazole is often distinguished in veterinary practice for its common dosing regimen, which requires administration for three or more consecutive days to ensure the complete clearance of certain parasites. This targeted, multi-day approach ensures the medication effectively clears parasites, a method utilized for its effectiveness in reducing parasite burden.

What side effects are possible with Exil No Worm?

Possible Side Effects and Safety Information

The safety profile for fenbendazole, the active ingredient in Exil No Worm, is formally defined by regulatory authorities based on classification by frequency and affected body system, reflecting how the medicine’s risks are officially communicated.

Adverse Reaction Scope

Component Description (Based on Regulatory Documentation)
Key adverse reaction categories Gastrointestinal disturbances and hypersensitivity (allergic) reactions.
Frequency classification Adverse effects are generally classified as uncommon or rare in official regulatory documents.
System-organ classes involved Gastrointestinal Disorders (e.g., vomiting, diarrhea) and Immune System Disorders (hypersensitivity).
Serious adverse reactions Severe hypersensitivity reactions (anaphylaxis) are documented as rare events. Bone marrow hypoplasia/pancytopenia has been reported in association with administration exceeding the officially approved duration (extra-label use).
Population-specific considerations Considered generally safe for use during pregnancy and lactation in target species when administered at the recommended therapeutic dose.

Safety Classifications (High-Level)

The officially documented adverse reactions are typically mild and transient, being primarily limited to uncommon or rare gastrointestinal effects. The most serious safety events, while rare, including bone marrow suppression, have been specifically associated with prolonged treatment or administration outside of the established regulatory parameters. Fenbendazole is formally contraindicated only in cases of known hypersensitivity to the active substance or its excipients.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation regarding the active substance, Fenbendazole, establishes the drug’s overdose profile based on its documented low toxicity and required emergency response.


Documented Overdose Manifestations and Actions

Property Official Regulatory Statement
Toxicity Profile Regulatory assessments document a wide margin of safety and low acute toxicity for the active ingredient.
Severe Outcomes Bone marrow hypoplasia and pancytopenia are documented as severe adverse events by the FDA Center for Veterinary Medicine, associated with extra-label, prolonged use.
Immediate Actions Seek medical advice immediately upon accidental ingestion or significant exposure. Procedural instructions advise to DO NOT induce vomiting.
Management Management is restricted to symptomatic and supportive treatment, as no specific antidote is known.

Required Emergency Response

Property Official Regulatory Statement
Urgent Medical Help Immediate medical help is required when accidental ingestion occurs or if exposure leads to any signs of toxicity, with management focused on providing supportive care.
Signs Observed Signs observed in non-clinical studies at very high doses include tremors (acute exposure) and diarrhoea (chronic exposure).

Regulatory documents define the overdose profile by emphasizing the substance's inherent low acute risk alongside the severe hematological risks linked to chronic, high-level exposure. This profile requires an explicit immediate medical response for accidental exposure, with subsequent care limited to supportive measures.

Therapeutic Uses of Exil No Worm

What Exil No Worm Treats: Main Uses and Benefits

The primary use of Exil No Worm is applied across therapeutic domains to address symptoms related to physical discomfort of parasitic worm infection. This medicine is commonly used to help with infections in patients experiencing conditions involving episodic or fluctuating manifestations, such as those caused by threadworms (pinworms), roundworm, whipworm, and hookworm. The treatment is considered relevant when supportive symptom management is appropriate for these common intestinal parasites.

This class of medication is applied in addressing the underlying infection that leads to these manifestations. This approach is commonly used during phases when symptoms become more noticeable and supportive relief is needed. In managing the underlying infection, the treatment contributes to improved comfort during periods of heightened symptoms associated with these conditions presenting with systemic or localized discomfort.

The medicine may assist with easing symptoms related to physical discomfort, such as restless sleep or anal itching, which are common signs of pinworm infection. The overall goal is to support general well-being during symptomatic phases. This treatment is relevant for easing symptoms linked to organ-specific functional stress.

Quick Fact: Relief for Symptoms related to physical discomfort (such as anal itching and restless sleep) may be part of symptomatic management in scenarios involving pinworm flare-ups.

Eligibility and Restrictions for Use

Who can and cannot use Exil No Worm?

The official eligibility profile for Exil No Worm (Fenbendazole) is strictly defined by its status as a veterinary medicine and its regulatory approvals for use in specific animal populations.


Contraindicated and Non-Eligible Populations

  • Humans: The product is strictly a veterinary drug and is not approved for use in humans by major regulatory authorities, making human use a fundamental contraindication.
  • Hypersensitivity: Animals with a confirmed history of hypersensitivity to fenbendazole or any of the product’s components are ineligible for treatment.
  • Age Restrictions: The medicine must not be given to puppies or kittens under 6 weeks of age.
  • State of Health: Sick animals must not be dewormed; use requires diagnosis and clearance from a veterinarian.
  • Food Animals: Use is prohibited in pre-ruminating calves intended for veal, and certain high-dose regimens are not approved for dairy cows of breeding age due to residue risk.

Conditional and Allowed Populations

  • Target Species: The medicine is allowed for its approved target animal species, including dogs, cats, pigs, cattle, and horses.
  • Pregnancy Status: Use is generally permitted in pregnant dogs, cattle, and laying hens. Restricted use is recommended during the first stage of pregnancy in pigs, requiring careful veterinary assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction profile for products containing the active ingredient, Fenbendazole, as defined by authoritative government regulatory agencies.


Interaction Scope

Category Official Regulatory Statement
Medicinal product categories with documented interactions None formally documented in official regulatory labels.
Specific interacting medicines None formally documented in official regulatory labels.
Mechanistic basis of interactions None formally documented as an interaction restriction or caution.
Timing-based interaction rules None formally documented in official regulatory labels.

Interaction Classifications (High-Level)

Category Official Regulatory Statement
Interaction severity classification None specified; the overall classification is one of an absence of known interactions.
Regulatory basis Based on the Summary of Product Characteristics (SmPC) from government health authorities.

Resulting Interaction Structure

The official regulatory documentation for products containing fenbendazole, such as the Summary of Product Characteristics (SmPC) issued by government health authorities, consistently declares that no interactions are known with other medicinal products, food, alcohol, or supplements. This formal regulatory statement dictates the absence of specific exposure-modifying, pharmacodynamic, or contraindicating combinations that require listing. Consequently, the official label lists no specific restrictions, prohibitions, or mandatory administration timing rules related to co-administration with other substances.

Mechanism of Action

How Exil No Worm Works

Neuromuscular Overstimulation in Parasites

This drug works by selectively binding to nicotinic acetylcholine receptors (nAChRs) on the somatic muscle cells of the target organisms, acting as a direct agonist. This targeted molecular interaction causes the parasite's muscle membranes to undergo continuous, irreversible depolarization, causing functional disruption of motor control by overloading its nerve-to-muscle signaling system.


Mechanistic Cascade to Spastic Paralysis

The sustained, uncontrolled electrical activation resulting from receptor overstimulation forces the parasite's muscles into a state of spastic (rigid) paralysis. This complete physiological incapacitation leads the organism to lose its ability to attach to the host's intestinal wall. This functional disruption in the parasite is the necessary antecedent, as it prepares the organism for subsequent mechanical removal.


Localized Action and Passive Expulsion

The active molecule is specifically formulated to remain concentrated within the intestinal lumen, targeting the parasites directly at their site of residence. This localized action is the physical condition for the final physiological effect: the normal muscular contractions (peristalsis) of the host's digestive tract passively sweep the detached and paralyzed organisms out of the body, resulting in the elimination of the paralyzed organisms.

Dosage and Administration Information

How to Use Exil No Worm

The usage of veterinary products containing fenbendazole, the active ingredient in Exil No Worm, follows specific administration and dosing protocols. The medicine is consistently administered via the oral route in formulations such as granules or suspensions.


Dosing and Treatment Schedule

Usage Aspect Administration Guideline
Standard Daily Dose 50 mg/kg of body weight
Frequency Once daily
Course Duration Three consecutive days per treatment course

The 50 mg/kg dose is calculated based on the animal's current weight. The treatment is structured as a three-day course which may be repeated semi-annually (twice each year) for adult animals as a maintenance practice.


Administration Contexts

Guidance indicates that the daily dose is administered with food. The medicine is mixed into a small amount of the animal's usual meal to ensure complete ingestion. For proper dosing, it is necessary for the animal to be accurately weighed; if the animal’s weight falls between specified dosing increments, using the next higher size is considered permissible and safe.

Fenbendazole products are used for specific groups, including pregnant animals and puppies six weeks of age or older. Newly weaned pups typically follow a scheduled course of administration (e.g., at 6, 8, 10, and 12 weeks of age) to manage early-life parasite burden.

Recent Clinical Evidence

Research evidence / Overview of Studies for Exil No Worm

This section provides a description of what has been observed in research settings. This information is not intended to offer personal medical advice or predict individual outcomes. Findings describe group patterns, not personal outcomes.


Evidence for use in Soil-Transmitted Helminths (STH) Infection

Research on conditions characterized by fluctuating or episodic manifestations, such as common infections like roundworm, whipworm, and hookworm (known collectively as Soil-Transmitted Helminths or STH), primarily includes Randomized Controlled Trials (RCTs) and Systematic Reviews. Research has explored how the infection markers change over a defined time interval.

Researchers have designed trials to measure the outcome known as the parasitological clearance rate (absence of parasite eggs in stool after administration), and the overall change in the intensity of the infection. The main populations evaluated were school-aged children and adults residing in endemic communities with varying symptom burdens. Trials reported measurements showing the absence of parasite eggs in stool samples at the short-term follow-up assessment point. Findings related to long-term outcomes, such as sustained growth or cognitive measures, were mixed and varied across different studies and populations.


Evidence for use in Other Specific Parasite Infections

For conditions involving periods of heightened symptoms caused by certain less common parasites, the evidence base generally consists of smaller-scale RCTs and published observational case series. These trials were studied for parasite outcomes and monitored the evolution of acute infection symptoms, such as physical discomfort. The existing evidence for these specific parasitic conditions remains limited and heterogeneous due to the modest sample sizes in most trials.


What is Still Uncertain About Exil No Worm Research

Research is ongoing, but the existing evidence landscape highlights what is known and what is still uncertain. Long-term effects are not fully established, and there is limited information for how outcomes reflecting daily functioning evolved. Results apply only to the populations studied. Research does not determine whether an individual will respond similarly. Follow-up durations were limited in many studies, contributing to the uncertainty regarding long-term outcomes.

Key Studies & References

  1. WHO Model List of Essential Medicines - Anthelmintics

Frequently Asked Questions (FAQ)

Common questions about Exil No Worm (FAQ)


Q: Is Exil No Worm the same as other medicines for the same condition?

A: Exil No Worm contains the active ingredient fenbendazole, which belongs to the benzimidazole class of anthelmintics. Official regulatory documents focus on its specific mechanism of action and note its required multi-day treatment course as a key characteristic when described alongside other treatments.

Q: Is it normal to feel a little dizzy after taking Exil No Worm?

A: Official regulatory documents do not list dizziness as a documented adverse reaction for fenbendazole in the approved target species. The officially reported adverse effects are typically limited to mild gastrointestinal issues or hypersensitivity (allergic) reactions.

Q: Why do people say Exil No Worm is a 'quick solution'?

A: The drug's mechanism of action is described in official sources as causing a rapid molecular effect that paralyzes the parasite. However, it is noted in product information that the full treatment course requires three consecutive days of administration for the intended outcome of organism clearance.

Q: How long does the effect of Exil No Worm typically last?

A: The drug is indicated for the clearance of parasites during its short treatment period. Pharmacokinetic data reviewed by regulatory bodies indicates that the active drug and its breakdown products (metabolites) may persist in the body for a few days after the final administration.

Q: Is Exil No Worm approved by regulatory bodies like the FDA or EMA?

A: Yes, products containing fenbendazole, such as Exil No Worm, are formally approved veterinary medicines that are regulated by government authorities worldwide, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Q: What does 'contraindication' mean in relation to Exil No Worm?

A: A contraindication is an official statement that describes a reason why a treatment should not be used. For this product, contraindications described in official documents include a known hypersensitivity (severe allergic reaction) to the drug or any of its inactive components, and use outside of the approved animal species.

Q: Is Exil No Worm considered a short-term or long-term treatment?

A: According to official regulatory labeling, it is classified as a short-term treatment. It is administered as a specific course of therapy, typically lasting for three consecutive days, which may be repeated at later intervals if needed for parasite control.

Q: What if I take too much Exil No Worm by accident?

A: Official regulatory safety data indicates that a single acute overdose is typically well-tolerated due to the drug's wide margin of safety. However, administration exceeding the approved duration is documented to be associated with serious adverse effects, such as bone marrow suppression.

Q: How quickly can I expect Exil No Worm to start working?

A: Official product information for fenbendazole generally indicates that the drug begins working against the target parasites within 1 to 2 days of the initial administration. The full three-day course is generally administered to support the intended clearance outcome.

Q: What happens if I miss a time I was supposed to take Exil No Worm?

A: Official regulatory instructions for a missed time typically outline options such as taking the missed dose if remembered soon, or skipping the missed dose and continuing with the regular schedule if it is near the time for the next dose. Double doses are generally not recommended.

Q: What is the difference between Exil No Worm and a prescription treatment?

A: The legal classification of fenbendazole can vary by the product formulation and country. Regulatory listings show that some versions are legally classified as an Over-the-Counter (OTC) Animal Drug, while other specific formulations may be listed as requiring a veterinarian's prescription.

Q: Is Exil No Worm available without a prescription in some places?

A: Yes, certain commercial product formulations containing fenbendazole are classified by regulatory agencies as an Over-the-Counter (OTC) Animal Drug. This means they are intended for sale without the requirement of a veterinarian's prescription.

Q: Does taking Exil No Worm affect liver function?

A: Fenbendazole is known to be metabolized primarily by the liver. While standard side effects are mainly digestive, prolonged or extra-label use, particularly at very high doses, has been associated in reports with potential changes to liver health.

Q: What if I take Exil No Worm and it doesn't seem to work?

A: Official guidelines note that if the animal's condition does not improve or worsens despite completing the full treatment course, seeking veterinary consultation for follow-up testing and evaluation is the next step.

Q: Does Exil No Worm cause weight changes?

A: Weight changes are not listed as a directly documented adverse reaction in the official regulatory safety documents. Reported side effects are generally limited to mild gastrointestinal issues, such as diarrhea or vomiting.

Q: Are there different strengths of Exil No Worm available?

A: Yes, the product is marketed in various regulated commercial formats. These may include granules or different concentrations of oral suspensions to allow for accurate dosing based on the animal's weight.

Q: Does Exil No Worm make you tired?

A: Tiredness or fatigue is not listed as a documented adverse reaction in the official regulatory safety documents. Adverse reaction profiles generally focus on digestive and immune system disorders.

Q: What should I do if a side effect of Exil No Worm feels severe?

A: Official product guidance describes that, in the event of a severe adverse effect (such as signs of a systemic allergic reaction), stopping the medication and seeking immediate veterinary evaluation or contacting an animal poison control center is the required response.

Q: Is the research evidence for Exil No Worm considered strong?

A: Regulatory reviews acknowledge that the drug's efficacy is supported by evidence, including the use of Randomized Controlled Trials (RCTs) to measure parasitological clearance. However, official information also notes that long-term data is limited for some health outcomes.

Q: What is the significance of the warning label on Exil No Worm packaging?

A: The warning label is included to convey essential regulatory requirements for the product. It highlights safety information, such as mandated precautions (like disposal rules), and documents the risks that were identified during the official drug approval process.

Q: Does Exil No Worm affect mental focus or concentration?

A: Official regulatory documents and adverse reaction profiles for fenbendazole do not list effects on mental focus or concentration. Documented adverse reactions are generally non-systemic and non-neurological in nature.

Q: Does Exil No Worm have a known risk of dependence?

A: Fenbendazole is not listed as a controlled substance by regulatory bodies. According to official regulatory profiles, the drug has no known risk of dependence or abuse potential.

Q: Does Exil No Worm contain gluten or common allergens?

A: The product contains the active ingredient fenbendazole plus other inactive components (excipients). Official product labels contraindicate use for known hypersensitivity to any excipient. Users are advised to check the full list of inactive ingredients on the product label for specifics regarding common allergens like lactose or starch.

Q: What is the legal status of Exil No Worm in different countries?

A: Fenbendazole products are legally categorized as approved veterinary medicines globally, but specific local controls can vary. The legal status (e.g., whether it is prescription-only or over-the-counter) often varies by country and depends on the specific product formulation.

Q: Is there a generic version of Exil No Worm?

A: Fenbendazole is the generic name of the active ingredient, and it is manufactured and marketed by multiple companies globally. Numerous other brand-name products containing fenbendazole are considered therapeutically equivalent to Exil No Worm.

Q: Are there any restrictions on activity while using Exil No Worm?

A: Official regulatory documents, including special precautions for use, do not list any specific restrictions on the animal's normal activity or exercise while the product is being administered.

How should Exil No Worm be stored and disposed of?

How to Store and Dispose of Exil No Worm?

The storage and disposal of Exil No Worm (fenbendazole) must adhere to official regulatory requirements to maintain product stability and protect the environment.

Storage Requirements

  • Temperature: Store at controlled room temperature, specifically between 68 F and 77 F (20 C to 25 C). The product must be kept away from heat and protected from light.
  • Handling: Do not freeze the liquid formulation, and keep the container tightly closed in the original packaging.
  • Safety: The medicine must be stored out of reach of children.
  • Stability: Stability limits apply after opening; for some liquid forms, the in-use shelf life is 6 months, and for medicated water, it is 24 hours.

Disposal Instructions

  • Disposal: Unused or expired product must be discarded in accordance with local requirements to an approved waste disposal facility.
  • Environmental Protection: Avoid release to the environment as the product is harmful to aquatic life. Do not flush the medication down the toilet or wash it down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Exil No Worm found in:

A-Z Index: